GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
Roche Bags Fast Track Label for New Alzheimer’s Diagnostic
2022-07-21
Alleviating Depression and Dementia with Transcorneal Electrical Stimulation
2022-07-11
Are Memory Loss in Alzheimer’s Disease Related to Changes in Blood Vessels in the Brain?
2022-07-07
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
FDA Greenlights First In-Vitro Alzheimer’s Diagnostic
2022-05-05
Biogen Halts Aduhelm’s Second EU Marketing Application
2022-04-25
The Brain Size Changes with Age: A First Worldwide Brain Study
2022-04-20
1 2 3 4 5 6
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
Scroll to Top